Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Mucus-degrating Bacteroides link carbapenem antibiotics to aggravated graft-versus-host-disease,

PROVIDER: PRJNA858490 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20214200_1.fastq.gz	Fastqsanger.gz
	SRR20214200_2.fastq.gz	Fastqsanger.gz
	SRR20214300_1.fastq.gz	Fastqsanger.gz
	SRR20214300_2.fastq.gz	Fastqsanger.gz
	SRR20214101.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 306

Similar Datasets

Project description:Mucus-degrating Bacteroides link carbapenem antibiotics to aggravated graft-versus-host-disease

| PRJNA858489 | ENA

Project description:Effects of broad-spectrum antibiotics on graft-versus-host disease

| PRJEB12959 | ENA

Project description:Bacteroides ovatus alleviates dysbiotic microbiota induced intestinal graft-versus-host disease

| PRJNA973955 | ENA

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Project description:RATIONALE: Beclomethasone may be an effective treatment for graft-versus-host disease. PURPOSE: Phase I/II trial to study the effectiveness of beclomethasone in treating patients who have graft-versus-host disease of the esophagus, stomach, small intestine, or colon.

| 2005776 | ecrin-mdr-crc

The effect of LCN2 treatment on anti-inflammatory bone marrow derived macrophages

Project description:Allogeneic hematopoietic stem cell transplantation remains the most efficacious treatment for many hematological malignancies. However, its therapeutic potential is affected by the most prominent side effect graft versus host disease. Despite advances in the treatment of graft versus host disease in recent years, morbidity and mortality remains high, which requires the development of new treatment approaches. We therefore implemented mouse models to assess potential treatment options for graft versus host disease. In in vivo experiments, we had observed a protective effect of LCN2 on graft versus host disease of the gastrointestinal tract. We also observed higher numbers of anti-inflammatory macrophages in the intestinal tissues of these animals. Therefore, we aimed to determine potentially regulated genes in these cells by using an in vitro approach of LCN2-treated macrophages.

2024-01-24 | GSE226432 | GEO

human feces metagenome (2705415)

Project description:The gut microbiota and graft versus host disease

| PRJNA1281039 | ENA

Homo sapiens

Project description:Acute graft-versus-host disease (gene expression profiling)

| PRJNA100457 | ENA

Project description:Host NLRP6 exacerbates graft-versus-host disease independent of microbial diversity

| PRJNA491725 | ENA

gut metagenome

Project description:Metagenomic next-generation sequencing of Graft-versus-Host disease

| PRJNA396964 | ENA